Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691119 · ClinicalTrials.gov registry record · NA
Relaxation and Visualization Therapy for Breast Cancer Patients
A NA study, sponsored by National University of Natural Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00691119: Clinical Trial NA study, sponsored by National University of Natural Medicine.
NCT00691119 is a NA study that was terminated before completion, run by National University of Natural Medicine. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00691119, a NA study, was terminated before completion, sponsored by National University of Natural Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if it is possible to study relaxation and visualization therapy (RVT) with individuals that have breast cancer. We will also look at what effects, the good and bad, RVT has when used with radiation therapy. We are interested in how RVT may relate to energy, quality of life, stress, and the immune system. Relaxation and Visualization therapy will lead participants through a practice of physical relaxation and then a step by step visualization. In this study, participants will be led through an RVT exercise, providing an interactive process. In addition, women will perform solitary RVT exercises at home on weekends. Participants for this study will be drawn from two OHSU physicians' regular patient base. To be sure that we are testing the effects of RVT alone, we will use three groups. The three groups will be RVT, education, and a control. The RVT group will receive RVT with radiation, and the education group will receive breast cancer related health education with radiation. The third group will receive no treatment beyond radiation. This third group is called the control. The entire study will last for approximately twelve weeks. For the first 6 weeks, each participant will be receiving radiation therapy. We will be particularly interested in the effects that RVT may have on energy, quality of life, stress, and the immune system. No experimental drug or device will be used during the study.
Interventions
- OTHER Health education
- BEHAVIORAL Relaxation and Visualization Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-12 |
| Phase | NA |
Why NCT00691119 stopped before completion
NCT00691119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Health education is the first listed.
NCT00691119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00691119 about?
NCT00691119 is a clinical study titled "Relaxation and Visualization Therapy for Breast Cancer Patients". The purpose of this study is to find out if it is possible to study relaxation and visualization therapy (RVT) with individuals that have breast cancer. We will also look at what effects, the good and bad, RVT has when used with radiation therapy. We are interested in how RVT may relate to energy, q...
What is the current status of trial NCT00691119?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2008-12. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00691119?
The interventions under investigation include: Health education (OTHER), Relaxation and Visualization Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00691119?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00691119's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia